Expertise in
6
conditions

Dr. Lei Z. Zheng

Holistic Medicine
Office
5572 Capital Center Dr, 
Raleigh, NC 
Expertise in
6
conditions
Office
5572 Capital Center Dr, 
Raleigh, NC 

Overview

Lei Zheng is a Holistic Medicine provider practicing medicine in Raleigh, North Carolina.

Ms. Zheng is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, Gallbladder Disease, Upper Tract Urothelial Carcinoma (UTUC), Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

She is actively involved in clinical research, co-authoring 1846 peer reviewed articles and participating in 6 clinical trials.

Specialties

Holistic Medicine

Licenses

Acupuncturist in NC

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
5572 Capital Center Dr, Raleigh, NC 27606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Platform Study of Combination Immunotherapy for the Neoadjuvant and Adjuvant Treatment of Patients With Surgically Resectable Adenocarcinoma of the Pancreas
A Platform Study of Combination Immunotherapy for the Neoadjuvant and Adjuvant Treatment of Patients With Surgically Resectable Adenocarcinoma of the Pancreas
Enrollment Status: Active_not_recruiting
Publish Date: June 01, 2026
Intervention Type: Drug, Biological
Study Drugs: Cyclophosphamide, GVAX pancreatic cancer, Nivolumab, Urelumab
Study Phase: Phase 2
A Phase I/II Trial of Combination Immunotherapy With Nivolumab and a CCR2/CCR5 Dual Antagonist (BMS-813160) With or Without GVAX Following Chemotherapy and Radiotherapy for Locally Advanced Pancreatic Ductal Adenocarcinomas (PDACs).
A Phase I/II Trial of Combination Immunotherapy With Nivolumab and a CCR2/CCR5 Dual Antagonist (BMS-813160) With or Without GVAX Following Chemotherapy and Radiotherapy for Locally Advanced Pancreatic Ductal Adenocarcinomas (PDACs).
Enrollment Status: Completed
Publish Date: May 11, 2026
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, CCR2/CCR5 dual antagonist, GVAX
Study Phase: Phase 1/Phase 2
A Phase II Study of GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine in Combination With PD-1 Blockade Antibody (Pembrolizumab) and Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Locally Advanced Adenocarcinoma of the Pancreas
A Phase II Study of GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine in Combination With PD-1 Blockade Antibody (Pembrolizumab) and Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Locally Advanced Adenocarcinoma of the Pancreas
Enrollment Status: Completed
Publish Date: March 13, 2026
Intervention Type: Radiation, Drug
Study Drugs: Cyclophosphamide, GVAX, Pembrolizumab
Study Phase: Phase 2
A Safety and Feasibility Trial of Boost Vaccinations of a Lethally Irradiated, Allogeneic Pancreatic Tumor Cell Vaccine Transfected With the GM-CSF Gene Given Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Surgically Resected Pancreatic Adenocarcinoma
A Safety and Feasibility Trial of Boost Vaccinations of a Lethally Irradiated, Allogeneic Pancreatic Tumor Cell Vaccine Transfected With the GM-CSF Gene Given Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Surgically Resected Pancreatic Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2025
Intervention Type: Biological, Drug
Study Drug: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine
Study Phase: Phase 2
Phase II Study to Evaluate Stereotactic Body Radiation Therapy For Palliative Management of Unresectable Recurrent or Residual Pancreatic or Periampullary Adenocarcinoma
Phase II Study to Evaluate Stereotactic Body Radiation Therapy For Palliative Management of Unresectable Recurrent or Residual Pancreatic or Periampullary Adenocarcinoma
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Radiation
Study Phase: Phase 2
A Multicenter, Single-blind, Pair-matched, Observational Clinical Trial of LUNSAFE
A Multicenter, Single-blind, Pair-matched, Observational Clinical Trial of LUNSAFE
Enrollment Status: Completed
Publish Date: March 21, 2025
Intervention Type: Diagnostic test, Procedure
View 5 Less Clinical Trials

1844 Total Publications

Orthogonal DNA barcoding enables subpopulation-resolved extracellular vesicle miRNA profiling.
Orthogonal DNA barcoding enables subpopulation-resolved extracellular vesicle miRNA profiling.
Journal: Science advances
Published: August 21, 2026
Similar Doctors
Expertise in
1
conditions
Dr. Scott A. Strine
Holistic Medicine | Neurology
Expertise in
1
conditions
Dr. Scott A. Strine
Holistic Medicine | Neurology
Referral required
Before you request

Duke Neurological Disorders Clinic - Clinic 1L

40 Duke Medicine Cir, 
Durham, NC 
 (21.9 miles away)
919-681-1700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Strine is a Holistic Medicine specialist and a Neurologist practicing medicine in Durham, North Carolina. Mr. Strine is highly rated in 1 condition, according to our data. His clinical expertise encompasses Peripheral Neuropathy, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Hereditary Neuralgic Amyotrophy. Mr. Strine is board certified in American Board Of Psychiatry/Neurology, Neurology. Mr. Strine is currently accepting new patients.

Expertise in
0
conditions
Li Lin
Holistic Medicine
Expertise in
0
conditions
Li Lin
Holistic Medicine
Referral may be required
310 Kildaire Rd, Suite 104, 
Chapel Hill, NC 
 (21.8 miles away)
919-590-9870
Languages Spoken:
English

Li Lin is a Holistic Medicine provider practicing medicine in Chapel Hill, North Carolina. Her clinical expertise encompasses Colonoscopy and Endoscopy.

Expertise in
0
conditions
Dr. Venus I. Pitts
Addiction Medicine | Pediatrics | Holistic Medicine
Expertise in
0
conditions
Dr. Venus I. Pitts
Addiction Medicine | Pediatrics | Holistic Medicine
Referral may be required
2609 N Duke St, 
Durham, NC 
 (22.7 miles away)
919-416-4700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Venus Pitts is an Addiction Medicine specialist and a Pediatrics provider practicing medicine in Durham, North Carolina. Her clinical expertise encompasses Oppositional Defiant Disorder (ODD), Opioid Use Disorder, and Muscle Spasms. Ms. Pitts is currently accepting new patients.

Frequently Asked Questions about Dr. Lei Z. Zheng

How do I make an appointment with Dr. Lei Z. Zheng?

You can book an appointment with Dr. Lei Z. Zheng by calling their office at 919-413-0421. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lei Z. Zheng a top-rated expert for Pancreatic Ductal Adenocarcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lei Z. Zheng is classified as an Elite expert for Pancreatic Ductal Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lei Z. Zheng specialize in?

While Dr. Lei Z. Zheng is a Holistic Medicine, they have specific expertise in Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Holistic Medicine.

Does Dr. Lei Z. Zheng participate in research or clinical trials?

Yes. Dr. Lei Z. Zheng has published 1844 articles and abstracts on conditions like Pancreatic Ductal Adenocarcinoma. You can view a list of Dr. Lei Z. Zheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zheng's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile